<DOC>
	<DOCNO>NCT01435525</DOCNO>
	<brief_summary>The purpose study confirm safety profile / factor impact safety efficacy patient give triple therapy Helicobacter pylorus eradication Nexium + amoxicillin ( AMPC ) + clarithromycin ( CAM ) , Nexium + AMPC + metronidazole ( MNZ ) usual post-marketing use .</brief_summary>
	<brief_title>Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation</brief_title>
	<detailed_description>Nexium capsule Specific Clinical Experience Investigation concern Helicobacter pylorus eradication</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Inclusion criterion : Triple therapy H.pylori eradication stomach start endoscopic treatment gastric ulcer Triple therapy H.pylori eradication stomach start endoscopic treatment duodenal ulcer Triple therapy H.pylori eradication stomach start endoscopic treatment gastric MALT lymphoma Triple therapy H.pylori eradication stomach start endoscopic treatment idiopathic thrombocytopenic purpura Triple therapy H.pylori eradication stomach start endoscopic treatment early gastric cancer H.pylori negative time triple therapy start</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>triple therapy</keyword>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>eradication</keyword>
	<keyword>Nexium</keyword>
</DOC>